Connect with us

Politics

iShares LifePath Target Date 2070 ETF Short Interest Drops 35.7%

editorial

Published

on

The short interest in the iShares LifePath Target Date 2070 ETF (NYSEARCA:ITDJ) experienced a notable decline in December 2023. As of December 31, the ETF reported a short interest of 6,183 shares, marking a decrease of 35.7% from the 9,621 shares reported on December 15. This reduction indicates a shift in investor sentiment towards the fund.

With an average daily trading volume of 2,787 shares, the current days-to-cover ratio stands at 2.2 days. This figure suggests that approximately 2.4% of the ETF’s shares are currently short sold, reflecting a cautious approach among investors.

Current Performance and Market Position

On Friday, shares of the iShares LifePath Target Date 2070 ETF traded at $30.07, with a slight increase of $0.01. The trading volume for the day reached 2,818 shares, which is below the average volume of 4,665 shares. The ETF has witnessed a one-year low of $21.27 and a one-year high of $30.22, indicating significant volatility throughout the year.

The fund’s performance metrics reflect a steady market presence with a 50-day moving average price of $29.38 and a 200-day moving average price of $28.52. Currently, the market capitalization of the iShares LifePath Target Date 2070 ETF is approximately $7.82 million, with a price-to-earnings (PE) ratio of 20.39 and a beta value of 0.98, suggesting it is slightly less volatile than the market average.

Investors interested in the iShares LifePath Target Date 2070 ETF can subscribe to receive updates and analyst ratings through various financial news platforms, ensuring they remain informed about significant changes and market movements related to the fund.

Continue Reading

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.